Versacross Access Solution
Payments companies reported to CMS as associated with Versacross Access Solution. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Versacross Access Solution, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Versacross Access Solution
These are the largest totals companies reported as associated with Versacross Access Solution. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Augustin Delago | Albany, NY | Cardiovascular Disease | $227,568.98 |
| David Callans | Philadelphia, PA | Clinical Cardiac Electrophysiology | $42,516.99 |
| Matthew Hyman | Philadelphia, PA | Clinical Cardiac Electrophysiology | $37,231.39 |
| Gagan Singh | Sacramento, CA | Cardiovascular Disease | $31,874.02 |
| Saurabh Sanon | Largo, FL | Interventional Cardiology | $29,112.20 |
| Jason Chinitz | Bay Shore, NY | $27,568.67 | |
| Paul Mahoney | Greenville, NC | Interventional Cardiology | $26,835.44 |
| Douglas Ebersole | Lakeland, FL | Interventional Cardiology | $25,138.04 |
| Bibhu Mohanty | Tampa, FL | Interventional Cardiology | $19,124.16 |
| Christopher Ellis | Nashville, TN | Cardiovascular Disease | $18,904.12 |
Prescribed Versacross Access Solution?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.